Daxor Corporation Announces $0.48 Per Share NAV Increase and Files Annual Report for Fiscal 2020
February 26, 2021 08:30 ET
|
Daxor Corporation
Revenues of Operating Division Increase by 50.4% NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) The global leader in blood volume technology today filed its Annual...
Global Technologies, Ltd Update on Corporate Operations
September 21, 2020 09:52 ET
|
Global Technologies, Ltd
Company Fully Reporting with Securities and Exchange Commission ST. PETERSBURG, FL, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Global Technologies, Ltd (OTC Pink: GTLL), a holding corporation, which...
Daxor Corporation Announces a 38 Percent Rise in BVA-100 Cardiology Kit Sales and Net Gain of $498,111 for Six Months in Filing of Form N-CSR for June 30, 2019
September 04, 2019 08:00 ET
|
Daxor Corporation
NEW YORK, Sept. 04, 2019 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) an investment company with innovative medical instrumentation and biotechnology operations focused on blood volume...